다제내성 임균감염

키워드

참고문헌 (43)

1. Fleming DT, "From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection", Sex Transm Infect, 75, pp.3~17
2. Tapsall JW, "Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae", Expert Rev Anti Infect Ther, 7, pp.821~834 (2009)
3. Centers for Disease Control and Prevention (CDC)., "Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections", MMWR Morb Mortal Wkly Rep, 61, pp.590~594 (2012)
4. "Study on antimicrobial resistance of Neisseria gonorrhoeae isolated in Korea"[URL]
5. Korenromp EL, "What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?", Int J STD AIDS, 13, pp.91~101 (2002)
6. 임동훈, "새로운 대한민국 성매개감염 진료지침", 대한요로생식기감염학회지, 6(1), pp.96~113 (2011), 대한요로생식기감염학회
7. "History of the medical treatment of gonorrhea"[URL]
8. Workowski KA, "Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies", Ann Intern Med, 148, pp.606~613 (2008)
9. Kampmeier RH, "Introduction of sulfonamide therapy for gonorrhea", Sex Transm Dis, 10, pp.81~84 (1983)
10. Centers for Disease Control (CDC), "CDC recommended treatment schedules, 1974", MMWR Morb Mortal Wkly Rep, 23, pp.341~347 (1974)
11. Centers for Disease Control (CDC), "1985 STD Treatment Guidelines", MMWR Morb Mortal Wkly Rep, 34(Suppl 4), pp.75S~108S (1985)
12. "1989 Sexually transmitted diseases treatment guidelines", MMWR Morb Mortal Wkly Rep, 38(Suppl 8), pp.1~43 (1989)
13. Centers for disease control and prevention., "1993 Sexually transmitted diseases treatment guidelines", MMWR Morb Mortal Wkly Rep, 42, pp.1~102 (1993)
14. Iverson CJ, "Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: role of foreign importation and increasing endemic spread", Sex Transm Dis, 31, pp.702~708 (2004)
15. Centers for Disease Control and Prevention (CDC), "Fluoroquinolone- resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999", MMWR Morb Mortal Wkly Rep, 49, pp.833~837 (2000)
16. Centers for Disease Control and Prevention (CDC), "Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001", MMWR Morb Mortal Wkly Rep, 51, pp.1041~1044 (2002)
17. Centers for Disease Control and Prevention (CDC), "Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004", MMWR Morb Mortal Wkly Rep, 53, pp.335~338 (2004)
18. Centers for Disease Control and Prevention (CDC), "Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections", MMWR Morb Mortal Wkly Rep, 56, pp.332~336 (2007)
19. Kirkcaldy RD, "Gonococcal resistance: are cephalosporins next?", Curr Infect Dis Rep, 13, pp.196~204 (2011)
20. Barry PM, "The use of cephalosporins for gonorrhea: the impending problem of resistance", Expert Opin Pharmacother, 10, pp.555~577 (2009)
21. Yokoi S, "Threat to cefixime treatment for gonorrhea", Emerg Infect Dis, 13, pp.1275~1277 (2007)
22. Unemo M, "Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010", Euro Surveill, 15, pp.19721~ (2010)
23. Ohnishi M, "Ceftriaxone-resistant Neisseria gonorrhoeae", Japan. Emerg Infect Dis, 17, pp.148~149 (2011)
24. Ohnishi M, "Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone", Antimicrob Agents Chemother, 55, pp.3538~3545 (2011)
25. Unemo M, "Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011", Euro Surveill, 17, pp.20200~ (2012)
26. Unemo M, "Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010", Euro Surveill, 16, pp.19792~ (2011)
27. "Gonococcal isolate surveillance project, GISP Profiles 2011 Introduction"[URL]
28. Tapsall JW, "Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1998. The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme", Commun Dis Intell, 24, pp.1~4 (2000)
29. Ito M, "Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones", Antimicrob Agents Chemother, 48, pp.3185~3187 (2004)
30. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme, "Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004", Commun Dis Intell Q Rep, 30, pp.129~132 (2006)
31. Lahra MM, "Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010", Commun Dis Intell Q Rep, 36, pp.95~100 (2012)
32. Workowski KA, "Sexually transmitted diseases treatment guidelines, 2010", MMWR Recomm Rep, 59, pp.1~110 (2010)
33. Moran JS, "Drugs of choice for the treatment of uncomplicated gonococcal infections", Clin Infect Dis, 20(Suppl 1), pp.S47~65 (1995)
34. Newman LM, "Update on the management of gonorrhea in adults in the United States", Clin Infect Dis, 44(Suppl 3), pp.S84~101 (2007)
35. Sathia L, "Pharyngeal gonorrhoea-is dual therapy the way forward?", Int J STD AIDS, 18, pp.647~648 (2007)
36. Ison CA, "Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010", Euro Surveill, 16, pp.19833~ (2010)
37. Unemo M, "First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011", Euro Surveil, 16, pp.19998~ (2011)
38. Yasuda M, "In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV", J Urol, 164, pp.847~851 (2000)
39. Ameyama S, "Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime", Antimicrob Agents Chemother, 46, pp.3744~3749 (2002)
40. Ito M, "Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan", Antimicrob Agents Chemother, 49, pp.137~143 (2005)
41. Deguchi T, "Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan", Ann Intern Med, 149, pp.363~364 (2008)
42. Matsumoto T, "Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae", Int J Antimicrob Agents, 31(Suppl 1), pp.S35~39 (2008)
43. Deguchi T, "Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae", Antimicrob Agents Chemother, 56, pp.4039~4040 (2012)

관련 논문AI추천